Researchers identify biomarkers that predict patient’s response to metformin treatment

Researchers identify biomarkers that predict patient’s response to metformin treatment

Researchers identify biomarkers that predict patient’s response to metformin treatment

Metformin is the first-line drug that can lower blood sugar levels in type 2 diabetes patients. One third of patients do not respond to metformin treatment and 5 per cent experience serious side effects, which is the reason many choose to stop medicating.